Last 12 months
Inside the activity.
0 purchase rows · 58 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 8 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 6 |
| May 2026 | 0 | 9 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 8 |
| Aug 2026 | 0 | 12 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 05, 2021 Filed Jan 6, 2021 22:51 UTC |
NOLAN KERMITSee Remarks
|
Exercise / conversionCommon Stock · Derivative | 1,049 | $0.00 Strike: $89.29 | $0.00 |
DisclosureSEC source: 0001209191-21-002305 · doc4.xml · derivative · entry 3 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,049 shares Expires 2022-10-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the October 23, 2015 date of grant, until fully vested on October 23, 2018. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 22:51 UTC |
NOLAN KERMITSee Remarks
|
SaleCommon Stock | 1,049 | $100.00 | $104,900.00 |
DisclosureSEC source: 0001209191-21-002305 · doc4.xml · nonDerivative · entry 2 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,711 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 18, 2020. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 22:51 UTC |
NOLAN KERMITSee Remarks
|
Exercise / conversionCommon Stock | 1,049 | $89.29 | $93,665.21 |
DisclosureSEC source: 0001209191-21-002305 · doc4.xml · nonDerivative · entry 1 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,760 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 30, 2020 Filed Jan 4, 2021 15:05 UTC |
NOLAN KERMITSee Remarks
|
Exercise / conversionCommon Stock · Derivative | 408 | $0.00 Strike: $79.38 | $0.00 |
DisclosureSEC source: 0001209191-21-000045 · doc4.xml · derivative · entry 5 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 408 shares Expires 2022-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the July 31, 2015 date of grant, until fully vested on July 31, 2018. Read SEC document |
| December 30, 2020 Filed Jan 4, 2021 15:05 UTC |
NOLAN KERMITSee Remarks
|
Exercise / conversionCommon Stock · Derivative | 408 | $0.00 Strike: $85.69 | $0.00 |
DisclosureSEC source: 0001209191-21-000045 · doc4.xml · derivative · entry 4 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 408 shares Expires 2022-04-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the April 24, 2015 date of grant, until fully vested on April 24, 2018. Read SEC document |
| December 30, 2020 Filed Jan 4, 2021 15:05 UTC |
NOLAN KERMITSee Remarks
|
SaleCommon Stock | 7,261 | $95.00 | $689,795.00 |
DisclosureSEC source: 0001209191-21-000045 · doc4.xml · nonDerivative · entry 3 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,711 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 18, 2020. Read SEC document |
| December 30, 2020 Filed Jan 4, 2021 15:05 UTC |
NOLAN KERMITSee Remarks
|
Exercise / conversionCommon Stock | 408 | $79.38 | $32,387.04 |
DisclosureSEC source: 0001209191-21-000045 · doc4.xml · nonDerivative · entry 2 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 30, 2020 Filed Jan 4, 2021 15:05 UTC |
NOLAN KERMITSee Remarks
|
Exercise / conversionCommon Stock | 408 | $85.69 | $34,961.52 |
DisclosureSEC source: 0001209191-21-000045 · doc4.xml · nonDerivative · entry 1 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2020 Filed Dec 29, 2020 22:43 UTC |
NOLAN KERMITSee Remarks
|
Exercise / conversionCommon Stock · Derivative | 745 | $0.00 Strike: $78.11 | $0.00 |
DisclosureSEC source: 0001209191-20-065392 · doc4.xml · derivative · entry 3 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 745 shares Expires 2021-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the August 1, 2014 date of grant, until fully vested on August 1, 2017. Read SEC document |
| December 28, 2020 Filed Dec 29, 2020 22:43 UTC |
NOLAN KERMITSee Remarks
|
SaleCommon Stock | 5,745 | $90.00 | $517,050.00 |
DisclosureSEC source: 0001209191-20-065392 · doc4.xml · nonDerivative · entry 2 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,156 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 18, 2020. Read SEC document |
| December 28, 2020 Filed Dec 29, 2020 22:43 UTC |
NOLAN KERMITSee Remarks
|
Exercise / conversionCommon Stock | 745 | $78.11 | $58,191.95 |
DisclosureSEC source: 0001209191-20-065392 · doc4.xml · nonDerivative · entry 1 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2020 Filed Dec 29, 2020 22:39 UTC |
Buchanan JeffreyDirector
|
SaleCommon Stock | 5,000 | $90.00 | $450,000.00 |
DisclosureSEC source: 0001209191-20-065391 · doc4.xml · nonDerivative · entry 1 BUCHANAN JEFFREY D · CIK 0001247555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,148 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 24, 2020. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 17:38 UTC |
Awsare SaleelSee Remarks
|
SaleCommon Stock | 139 | $79.60 | $11,064.40 |
DisclosureSEC source: 0001209191-20-058987 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,308 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020, as amended by that certain First Amendment dated March 13, 2020. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 00:18 UTC |
McFarland JohnSVP, General Counsel & Sec.
|
SaleCommon Stock | 300 | $84.50 | $25,348.50 |
DisclosureSEC source: 0001209191-20-057779 · doc4.xml · nonDerivative · entry 4 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,860 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.49 to $84.50, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 00:18 UTC |
McFarland JohnSVP, General Counsel & Sec.
|
SaleCommon Stock | 4,383 | $83.38 | $365,472.95 |
DisclosureSEC source: 0001209191-20-057779 · doc4.xml · nonDerivative · entry 3 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,160 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.00 to $83.96, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 00:18 UTC |
McFarland JohnSVP, General Counsel & Sec.
|
SaleCommon Stock | 2,097 | $82.41 | $172,805.17 |
DisclosureSEC source: 0001209191-20-057779 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,543 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.00 to $82.95, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 00:18 UTC |
McFarland JohnSVP, General Counsel & Sec.
|
SaleCommon Stock | 3,695 | $81.60 | $301,510.89 |
DisclosureSEC source: 0001209191-20-057779 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,640 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.00 to $81.99, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 00:15 UTC |
Hardman SusanDirector
|
SaleCommon Stock | 376 | $83.50 | $31,396.00 |
DisclosureSEC source: 0001209191-20-057778 · doc4.xml · nonDerivative · entry 1 HARDMAN SUSAN J · CIK 0001185652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,955 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated August 10, 2020. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 00:12 UTC |
Awsare SaleelSee Remarks
|
SaleCommon Stock | 300 | $84.49 | $25,347.00 |
DisclosureSEC source: 0001209191-20-057775 · doc4.xml · nonDerivative · entry 4 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,447 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.47 to $84.50, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 00:12 UTC |
Awsare SaleelSee Remarks
|
SaleCommon Stock | 3,112 | $83.43 | $259,648.48 |
DisclosureSEC source: 0001209191-20-057775 · doc4.xml · nonDerivative · entry 3 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,747 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.12 to $83.92, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 00:12 UTC |
Awsare SaleelSee Remarks
|
SaleCommon Stock | 1,720 | $82.58 | $142,045.34 |
DisclosureSEC source: 0001209191-20-057775 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,859 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.11 to $83.08, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 00:12 UTC |
Awsare SaleelSee Remarks
|
SaleCommon Stock | 3,364 | $81.61 | $274,528.30 |
DisclosureSEC source: 0001209191-20-057775 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,579 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.10 to $82.09, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 00:10 UTC |
Allgood Kiva A.Director
|
SaleCommon Stock | 300 | $83.50 | $25,050.00 |
DisclosureSEC source: 0001209191-20-057773 · doc4.xml · nonDerivative · entry 1 Allgood Kiva A. · CIK 0001778208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,026 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 20, 2020. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 00:08 UTC |
Butler Dean WarrenSee Remarks
|
SaleCommon Stock | 200 | $84.49 | $16,898.00 |
DisclosureSEC source: 0001209191-20-057771 · doc4.xml · nonDerivative · entry 4 Butler Dean Warren · CIK 0001791047 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,534 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 20, 2020. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 00:08 UTC |
Butler Dean WarrenSee Remarks
|
SaleCommon Stock | 2,233 | $83.43 | $186,293.61 |
DisclosureSEC source: 0001209191-20-057771 · doc4.xml · nonDerivative · entry 3 Butler Dean Warren · CIK 0001791047 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,734 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 20, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.13 to $83.90, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 00:08 UTC |
Butler Dean WarrenSee Remarks
|
SaleCommon Stock | 1,942 | $82.61 | $160,420.46 |
DisclosureSEC source: 0001209191-20-057771 · doc4.xml · nonDerivative · entry 2 Butler Dean Warren · CIK 0001791047 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,967 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 20, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.09 to $83.07, inclusive. The reporting person undertakes to provide to the Company , any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 00:08 UTC |
Butler Dean WarrenSee Remarks
|
SaleCommon Stock | 2,939 | $81.66 | $239,989.34 |
DisclosureSEC source: 0001209191-20-057771 · doc4.xml · nonDerivative · entry 1 Butler Dean Warren · CIK 0001791047 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,909 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 20, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.09 to $82.04, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 17:30 UTC |
Hardman SusanDirector
|
GrantCommon Stock | 2,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056843 · doc4.xml · nonDerivative · entry 1 HARDMAN SUSAN J · CIK 0001185652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,331 F1 · shares: 25% of the total number of deferred stock units shall vest each quarter until fully vested on October 31, 2021, or for a Director not standing for re-election, the date of the Issuer's 2021 Annual Meeting of Stockholders. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 17:26 UTC |
Chan NelsonDirector
|
GrantCommon Stock | 2,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056842 · doc4.xml · nonDerivative · entry 1 CHAN NELSON C · CIK 0001242653 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,210 F1 · shares: 25% of the total number of deferred stock units shall vest each quarter until fully vested on October 31, 2021, or for a Director not standing for re-election, the date of the Issuer's 2021 Annual Meeting of Stockholders. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 17:23 UTC |
Geeslin KeithDirector
|
GrantCommon Stock | 2,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056839 · doc4.xml · nonDerivative · entry 1 GEESLIN KEITH · CIK 0001196198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,863 F1 · shares: 25% of the total number of deferred stock units shall vest each quarter until fully vested on October 31, 2021, or for a Director not standing for re-election, the date of the Issuer's 2021 Annual Meeting of Stockholders. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 17:20 UTC |
Whims JamesDirector
|
GrantCommon Stock | 2,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056838 · doc4.xml · nonDerivative · entry 1 WHIMS JAMES L · CIK 0001216815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,229 F1 · shares: 25% of the total number of deferred stock units shall vest each quarter until fully vested on October 31, 2021, or for a Director not standing for re-election, the date of the Issuer's 2021 Annual Meeting of Stockholders. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 17:18 UTC |
Buchanan JeffreyDirector
|
GrantCommon Stock | 2,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056836 · doc4.xml · nonDerivative · entry 1 BUCHANAN JEFFREY D · CIK 0001247555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,148 F1 · shares: 25% of the total number of deferred stock units shall vest each quarter until fully vested on October 31, 2021, or for a Director not standing for re-election, the date of the Issuer's 2021 Annual Meeting of Stockholders. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 17:12 UTC |
Allgood Kiva A.Director
|
GrantCommon Stock | 2,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056835 · doc4.xml · nonDerivative · entry 1 Allgood Kiva A. · CIK 0001778208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,326 F1 · shares: 25% of the total number of deferred stock units shall vest each quarter until fully vested on October 31, 2021, or for a Director not standing for re-election, the date of the Issuer's 2021 Annual Meeting of Stockholders. Read SEC document |
| October 31, 2020 Filed Nov 3, 2020 22:51 UTC |
HURLSTON MICHAEL E.Director · See remarks below
|
Tax withholdingCommon Stock | 6,424 | $76.67 | $492,528.08 |
DisclosureSEC source: 0001209191-20-056724 · doc4.xml · nonDerivative · entry 3 HURLSTON MICHAEL E. · CIK 0001573338 · Director · See remarks below 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,362 F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. Read SEC document |
| October 31, 2020 Filed Nov 3, 2020 22:51 UTC |
HURLSTON MICHAEL E.Director · See remarks below
|
Tax withholdingCommon Stock | 12,846 | $76.67 | $984,902.82 |
DisclosureSEC source: 0001209191-20-056724 · doc4.xml · nonDerivative · entry 2 HURLSTON MICHAEL E. · CIK 0001573338 · Director · See remarks below 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,786 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance-based market stock units. Read SEC document |
| October 31, 2020 Filed Nov 3, 2020 22:51 UTC |
HURLSTON MICHAEL E.Director · See remarks below
|
GrantCommon Stock | 24,540 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056724 · doc4.xml · nonDerivative · entry 1 HURLSTON MICHAEL E. · CIK 0001573338 · Director · See remarks below 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,632 F1 · shares: Reflects shares released in connection with the vesting of performance-based market stock units granted on October 31, 2019. Read SEC document |
| October 31, 2020 Filed Nov 3, 2020 22:48 UTC |
Butler Dean WarrenSee Remarks
|
Tax withholdingCommmon Stock | 7,137 | $76.67 | $547,193.79 |
DisclosureSEC source: 0001209191-20-056721 · doc4.xml · nonDerivative · entry 2 Butler Dean Warren · CIK 0001791047 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,848 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance-based market stock units. Read SEC document |
| October 31, 2020 Filed Nov 3, 2020 22:48 UTC |
Butler Dean WarrenSee Remarks
|
GrantCommon Stock | 13,634 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056721 · doc4.xml · nonDerivative · entry 1 Butler Dean Warren · CIK 0001791047 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,985 F1 · shares: Reflects shares released in connection with the vesting of performance-based market stock units granted on October 31, 2019. Read SEC document |
| October 31, 2020 Filed Nov 3, 2020 22:45 UTC |
Awsare SaleelSee Remarks
|
Tax withholdingCommon Stock | 5,023 | $76.67 | $385,113.41 |
DisclosureSEC source: 0001209191-20-056720 · doc4.xml · nonDerivative · entry 3 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,943 F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. Read SEC document |
| October 31, 2020 Filed Nov 3, 2020 22:45 UTC |
Awsare SaleelSee Remarks
|
Tax withholdingCommon Stock | 5,231 | $76.67 | $401,060.77 |
DisclosureSEC source: 0001209191-20-056720 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,966 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance-based market stock units. Read SEC document |
| October 31, 2020 Filed Nov 3, 2020 22:45 UTC |
Awsare SaleelSee Remarks
|
GrantCommon Stock | 9,993 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056720 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,197 F1 · shares: Reflects shares released in connection with the vesting of performance-based market stock units granted on December 13, 2017 and October 31, 2019. Read SEC document |
| October 31, 2020 Filed Nov 3, 2020 22:39 UTC |
McFarland JohnSVP, General Counsel & Sec.
|
Tax withholdingCommon Stock | 5,236 | $76.67 | $401,444.12 |
DisclosureSEC source: 0001209191-20-056717 · doc4.xml · nonDerivative · entry 3 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,335 F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. Read SEC document |
| October 31, 2020 Filed Nov 3, 2020 22:39 UTC |
McFarland JohnSVP, General Counsel & Sec.
|
Tax withholdingCommon Stock | 6,266 | $76.67 | $480,414.22 |
DisclosureSEC source: 0001209191-20-056717 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,571 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance-based market stock units. Read SEC document |
| October 31, 2020 Filed Nov 3, 2020 22:39 UTC |
McFarland JohnSVP, General Counsel & Sec.
|
GrantCommon Stock | 11,971 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056717 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,837 F1 · shares: Reflects shares released in connection with the vesting of performance-based market stock units granted on October 31, 2017, November 13, 2018 and October 31, 2019. Read SEC document |
| October 31, 2020 Filed Nov 3, 2020 22:33 UTC |
NOLAN KERMITSee Remarks
|
Tax withholdingCommon Stock | 3,323 | $76.67 | $254,774.41 |
DisclosureSEC source: 0001209191-20-056711 · doc4.xml · nonDerivative · entry 3 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,156 F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. Read SEC document |
| October 31, 2020 Filed Nov 3, 2020 22:33 UTC |
NOLAN KERMITSee Remarks
|
Tax withholdingCommon Stock | 2,175 | $76.67 | $166,757.25 |
DisclosureSEC source: 0001209191-20-056711 · doc4.xml · nonDerivative · entry 2 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,479 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance-based market stock units. Read SEC document |
| October 31, 2020 Filed Nov 3, 2020 22:33 UTC |
NOLAN KERMITSee Remarks
|
GrantCommon Stock | 4,498 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056711 · doc4.xml · nonDerivative · entry 1 NOLAN KERMIT · CIK 0001767271 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,654 F1 · shares: Reflects shares released in connection with the vesting of performance-based market stock units granted on December 13, 2017 and October 31, 2019. Read SEC document |
| October 21, 2020 Filed Oct 23, 2020 17:28 UTC |
Butler Dean WarrenSee Remarks
|
Tax withholdingCommon Stock | 2,685 | $78.98 | $212,061.30 |
DisclosureSEC source: 0001209191-20-055652 · doc4.xml · nonDerivative · entry 1 Butler Dean Warren · CIK 0001791047 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,351 F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 21:16 UTC |
McFarland JohnSVP, General Counsel & Sec.
|
SaleCommon Stock | 1,403 | $83.41 | $117,022.55 |
DisclosureSEC source: 0001209191-20-054680 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,866 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.35 to $83.49, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 21:16 UTC |
McFarland JohnSVP, General Counsel & Sec.
|
SaleCommon Stock | 7,811 | $82.92 | $647,717.80 |
DisclosureSEC source: 0001209191-20-054680 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,269 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.35 to $83.34, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.